Literature DB >> 21999238

Inhibitory effect of blueberry polyphenolic compounds on oleic acid-induced hepatic steatosis in vitro.

Yixiang Liu1, Dan Wang, Di Zhang, Yechun Lv, Ying Wei, Wei Wu, Feng Zhou, Miaomiao Tang, Ting Mao, Mengmeng Li, Baoping Ji.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic liver diseases worldwide and is closely associated with metabolic syndromes, such as obesity, diabetes, and insulin resistance. Nonalcoholic fatty liver (NAFL), also called simple steatosis, is the initial phase of NAFLD, which is accompanied the characteristic pathological overaccumulation of lipids without inflammation. To prevent NAFLD from reaching the NAFL stage through dietary therapy, in the present work, wild Chinese blueberries (Vacciniun spp.) were selected for their well-known benefits in inhibiting metabolic syndrome. After being purified from wild Chinese blueberries, polyphenol-rich extracts were subsequently separated into three fractions, namely, anthocyanin-rich fraction, phenolic acid-rich fraction, and ethyl acetate extract. The inhibition of oleic acid (OA)-induced triglyceride (TG) deposition in HepG 2 cells was referred to as the potential activity of preventing NAFL. Biochemical indicators, such as cytotoxicity, TG level, levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and intracellular reactive oxygen species, were used to evaluate the analogous pathological stage of NAFLD. The results show that OA ≤ 1.0 mM exhibits a dose-dependent induction of TG accumulation, and no inflammation was observed based on the changes in ALT and AST levels. Therefore, 1.0 mM OA was used to simulate an in vitro fatty liver. Blueberry polyphenol-rich extract efficiently inhibited OA-induced TG accumulation in HepG2 cells, and the phenolic acid-rich fraction performed efficiently. Seven phenolic acids were subsequently identified using a high-performance liquid chromatography assay, and the main types were caffeic, chlorogenic, ferulic, p-coumaric, and cinnamic acids. These phenolic acid standards also displayed good efficiency in inhibiting TG accumulation in HepG2 cells. These results imply that wild Chinese blueberries have a potential preventive effect on NAFLD in its early stage, and phenolic acids are the most efficient component.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21999238     DOI: 10.1021/jf203136j

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  16 in total

Review 1.  Herbal medicines and nonalcoholic fatty liver disease.

Authors:  Hong Yao; Yu-Jie Qiao; Ya-Li Zhao; Xu-Feng Tao; Li-Na Xu; Lian-Hong Yin; Yan Qi; Jin-Yong Peng
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

2.  Anthocyanins-rich extract of wild Chinese blueberry protects glucolipotoxicity-induced INS832/13 β-cell against dysfunction and death.

Authors:  Jia Liu; Fengyi Gao; Baoping Ji; Ruojun Wang; Junsi Yang; Huijun Liu; Feng Zhou
Journal:  J Food Sci Technol       Date:  2014-04-26       Impact factor: 2.701

3.  Pepsin-digested chicken-liver hydrolysate attenuates hepatosteatosis by relieving hepatic and peripheral insulin resistance in long-term high-fat dietary habit.

Authors:  Yi-Hsieng Samuel Wu; Yi-Ling Lin; Wen-Yuan Yang; Sheng-Yao Wang; Yi-Chen Chen
Journal:  J Food Drug Anal       Date:  2021-06-15       Impact factor: 6.157

Review 4.  Effects of resveratrol and other polyphenols in hepatic steatosis.

Authors:  Leixuri Aguirre; Maria Puy Portillo; Elizabeth Hijona; Luis Bujanda
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

5.  Hypolipidemic Activity of Camellia euphlebia Flower Extract in High-fat-fed Mice.

Authors:  Dongye He; Ping Zhang; Xuan Sai; Xiaoyu Li; Lili Wang; Yongping Xu
Journal:  Plant Foods Hum Nutr       Date:  2017-12       Impact factor: 3.921

6.  In Vitro Screening for Antihepatic Steatosis Active Components within Coptidis Rhizoma Alkaloids Extract Using Liver Cell Extraction with HPLC Analysis and a Free Fatty Acid-Induced Hepatic Steatosis HepG2 Cell Assay.

Authors:  Hui Fan; Yuan-Yuan Chen; Wei-Jian Bei; Lai-You Wang; Bao-Tian Chen; Jiao Guo
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-18       Impact factor: 2.629

7.  Toll-like receptor 7 affects the pathogenesis of non-alcoholic fatty liver disease.

Authors:  Sokho Kim; Surim Park; Bumseok Kim; Jungkee Kwon
Journal:  Sci Rep       Date:  2016-06-09       Impact factor: 4.379

8.  Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds.

Authors:  Cicero L T Chang; Yenshou Lin; Arlene P Bartolome; Yi-Ching Chen; Shao-Chih Chiu; Wen-Chin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-04       Impact factor: 2.629

Review 9.  Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease.

Authors:  Luca Valenti; Patrizia Riso; Alessandra Mazzocchi; Marisa Porrini; Silvia Fargion; Carlo Agostoni
Journal:  Oxid Med Cell Longev       Date:  2013-10-24       Impact factor: 6.543

Review 10.  Cell Systems to Investigate the Impact of Polyphenols on Cardiovascular Health.

Authors:  Charlotte Grootaert; Senem Kamiloglu; Esra Capanoglu; John Van Camp
Journal:  Nutrients       Date:  2015-11-11       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.